The course runs over 13 weeks with the final week confined to assessment by face-to-face participation in an OSCE style format using a number of multidisciplinary team (MDT) meeting scenarios. The emphasis is on multimodality patient care which offers the best chance for a favourable outcome for a variety of common tumour types including breast, colorectal, prostate, gastro-oesophageal junction and melanoma. The unit is designed to address each cancer type with an overview highlighting those issues of importance when discussing management at an MDT meeting including: anatomical pathology desciption of the tumour, clinicopathological staging, pathology ,staging, advances in Molecular Biology, Imaging, Surgery, Radiation and Medical oncology, new biologic therapies and the place of palliation of advanced disease. The emphasis is largely on self- directed learning with on-line lectures and reading material provided by a Faculty of clinicians drawn from various metropolitan teaching hospitals. Specific Learning objectives: 1) to develop the skills to advocate evidence-based management for the individual needs of a patient in an MDT meeting and to understand the contribution of each clinical discipline in the decision making process 2) to demonstrate an adequate back ground knowledge of the natural history and classification of common tumours 3) to formulate a cancer specific management plan based on standardised reporting of the extent of tumour burden 4) to understand the influence of evidence-based, independent prognostic factors on outcomes and evolving concepts in cancer biology.
Unit details and rules
Academic unit | Surgery |
---|---|
Credit points | 6 |
Prerequisites
?
|
PATH5000 |
Corequisites
?
|
None |
Prohibitions
?
|
None |
Assumed knowledge
?
|
Candidates are expected generally to be undertaking advanced surgical training or similar |
Available to study abroad and exchange students | No |
Teaching staff
Coordinator | Brett Hambly, brett.hambly@sydney.edu.au |
---|